Synthesis of optically pure (R)-5-(2-aminopropyl)-2-methoxybenze nesulphonamide

Details for Australian Patent Application No. 2004309314 (hide)

Owner Lek Pharmaceuticals d.d.

Inventors Mohar, Barbara

Agent Griffith Hack

Pub. Number AU-B-2004309314

PCT Pub. Number WO2005/063701

Priority P-200300320 29.12.03 SI

Filing date 27 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 1 September 2011

International Classifications

C07C 303/08 (2006.01) Preparation of esters or amides of sulfuric acids

C07C 303/38 (2006.01) Preparation of esters or amides of sulfuric acids

C07C 303/40 (2006.01) Preparation of esters or amides of sulfuric acids

C07C 311/37 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/46 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 309/51 (2006.01) Sulfonic acids

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063701 Priority application(s): WO2005/063701

1 September 2011 Application Accepted

  Published as AU-B-2004309314

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309315-Preparation of R5-(2-(2-ethoxyphenoxyetylamino)propyl )-2methoxybenzenesulphonamide hydrochloride of high chemical

2004309313-Process for preparing amorphous (4R-cis)-6-[2-[3-phenyl-4-(phenylcarba moyl)-2-(4-fluorophenyl)-5-(1-methyleth yl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]- dioxane-4-yl-acetic acid